维普中文期刊产品整合服务
845篇 您的检索式:作者名="S Carr"
    题名 作者 年代 出处 被引量
1Current concepts in ameloblastoma-targeted therapies in B-raf proto-oncogene serine/threonine kinase V600E mutation: Systematic review显示文摘BACKGROUND Ameloblastomas are common benign epithelial odontogenic neoplasms that present an aggressive and unpredictable behavior that may modify treatment strategies.Different signaling pathways that participate in the progression of these tumors have been identified.B-raf proto-oncogene serine/threonine kinase(BRAF)is a protein involved in the behavior of ameloblastomas,and it is related to many cell mechanisms.BRAF gene mutations have been identified in ameloblastomas,of which the BRAF V600E(valine substituted by glutamic acid at amino acid 600)mutation has been the most common and can be present concomitantly with other mutations that may be involved in its behavior.Targeted therapies have been used as an alternative in the case of resistance or contraindications to conventional treatments.AIM To document the presence of BRAF V600E and additional mutations,their behavior,and targeted therapies in these tumors.METHODS An electronic literature search was conducted according to PRISMA guidelines in PubMed/MEDLINE,Cochrane,EMBASE,and SpringerLink using the terms“ameloblastomas”,“BRAF V600E”,“additional mutations”,and“targeted therapies”.Ameloblastomas were classified according to WHO guidelines.Inclusion criteria were articles in English,published not more than 10 years ago,and studies with laboratory works related to BRAF V600E.Articles were evaluated by two independent reviewers and retrieved for full-text evaluation.The EBLIP Critical Appraisal Checklist was used to evaluate the quality of the eligible studies.Descriptive statistical analysis was performed.RESULTS Two independent reviewers,with a substantial concordance indicated by a kappa coefficient of k=0.76,evaluated a total of 19 articles that were included in this study.The analysis registered 521 conventional ameloblastomas(AM),81 unicystic ameloblastomas(UA),13 ameloblastic carcinomas(AC),three metastatic ameloblastomas(MA),and six peripheral ameloblastomas(PA),of which the histopathological type,anatomic location,laboratory tests,expression of BRAF mutation,and additional mutations were registered.The BRAF V600E mutation was found in 297 AM(57%),63 UA(77.7%),3 AC(23%),1 MA(50%),and 5 PA(83.3%).Follicular type predominated with a total of 116 cases(40%),followed by plexiform type with 63 cases(22.1%).Furthermore,both types presented additional mutations,in which alterations in JAK3 P132T,SMARCB1,PIK3CA,CTNNB1,SMO,and BRAF G606E genes were found.Four case reports were found with targeted therapy to BRAF V600E.CONCLUSION The identification of BRAF V600E and additional mutations as an aid in targeted therapies has been a breakthrough in alternative treatments of ameloblastomas where surgical treatments are contraindicated.Rogelio González-González Sandra López-Verdín Jesús Lavalle-Carrasco Nelly Molina-Frechero Mario Isiordia-Espinoza Ramón G Carreón-Burciaga Ronell Bologna-Molina 2020World Journal of Clinical Oncology2020,11,1:6
2通过业余时间运动的中老年的运动心电图:100次运动试验足以确定一个无症状心肌缺血的心脏事件风险显示文摘运动心电图在预防运动员心脏事件方面的重要性一直存在争议。为了确定运动心电图中无症状心肌缺血(silent myocardial ischemia,SMI)的频率及运动心电图与冠状动脉造影评估结果和潜在可预防的心脏事件的关系。Hupin等纳入2011-2014年就诊于Saint-Etienne大学医院运动医学科年龄≥35岁的无症状业余运动员,进行前瞻性队列研究。刘青 叶鹏 Hupin D Edouard P Oriol M Laukkanen J Abraham P Doutreleau S Guy JM CarréF Barthélémy JC Roche F Chatard JC 2018中华高血压杂志2018,26,4:6
3Pretreatment methods to improve sludge anaerobic degradability: A review显示文摘H. Carrère C. Dumas A. Battimelli D.J. Batstone J.P. Delgenès J.P. Steyer I. Ferrer 2010Journal of Hazardous Materials2010,,1:5
4MicroRNAs as emerging biomarkers and therapeutic targets for pancreatic cancer显示文摘Despite tremendous efforts from scientists and clinicians worldwide, pancreatic adenocarcinoma(PDAC) remains a deadly disease due to the lack of early diagnostic tools and reliable therapeutic approaches. Consequently, a majority of patients(80%) display an advanced disease that results in a low resection rate leading to an overall median survival of less than 6 months. Accordingly, robust markers for the early diagnosis and prognosis of pancreatic cancer, or markers indicative of survival and/or metastatic disease are des-perately needed to help alleviate the dismal prognosis of this cancer. In addition, the discovery of new therapeutic targets is mandatory to design effective treatments. In this review, we will highlight the translational studies demonstrating that microRNAs may soon translate into clinical applications as long-awaited screening tools and therapeutic targets for PDAC.Marion Gayral Sébastien Jo Naima Hanoun Alix Vignolle-Vidoni Hubert Lulka Yannick Delpu Aline Meulle Marlène Dufresne Marine Humeau Maёl Chalret du Rieu Barbara Bournet Janick Sèlves Rosine Guimbaud Nicolas Carrère Louis Buscail Jérome Torrisani Pierre Cordelier 2014World Journal of Gastroenterology2014,20,32:4
5Molecular genetics of berry colour variation in table grape显示文摘Diego Lijavetzky Leonor Ruiz-García José A. Cabezas María T. Andrés Gemma Bravo Ana Ibá?ez Juan Carre?o Félix Cabello Javier Ibá?ez José M. Martínez-Zapater 2006Molecular Genetics and Genomics2006,,5:2
6The comparative effects of Postoperative analgesic therapies on pulmonary outcome: cumulative meta-analyses of randomiIed, controlled trials 显示文摘Ballantyne JC Carr DB deFerranti S 1998Anesth Analg1998,86,3:1
7Human tryptase fibrinogenolysis is optimal at acidic pH and generates anticoagulant fragments in the presence of the anti - tryptase monoclonal antibody B12显示文摘 Lawson AE Carr M 1997J Immunol1997,159,7:1
8Computed tomographic assessment of fractures of the posterior wall of the acetabulum after operative treatment显示文摘Moed B R Willson Carr S E Gruson K I 2007J Bone Joint Surg Am2007,85,3:1
9Development and evaluation of sediment quality guidelines for Florida coastal waters显示文摘MACDONALD D D CARR R S CALDER F D 1996Ecotoxicology1996,5,:1
10Assessment of the novel selective aldosterone blocker eplerenone using ambulatory and clinical bloodpressure in patients with systemic hypertension显示文摘White WB Carr AA Krause S 2003Am J Cardiol2003,92,1:1
11Battery energy storage technologies显示文摘Anderson M D Carr D S 1993Proceedings of the IEEE1993,81,3:1
12Correlation of the diame- ter of the left common iliae vein with the risk of lower-ex- tremity deep venous thrombosis 显示文摘Carr S Chart K Rosenberg J 2012Vasc Interv Radiol2012,23,11:1
13Insights and new direc- tions from demand-side approaches to technology inno- vation, entrepreneurship, and strategic management re- search显示文摘Priem R L Li S Carr J C 2012Journal of Management2012,38,1:1
14Nanofabrication and electrostatic operation of single- crystal silicon paddle oscillators 显示文摘EvoY S CARR D W SEKARIC L 1999Journal of Applied Physics1999,86,:1
15Crystal structures of MMP-1 and MMP-13 reveal the structural basis for selectivityof collagenase inhibitors显示文摘 Welch AR Carr S 1999Nat Struct Biol1999,6,3:1
16Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome 显示文摘HADI H A CARR C S SUWAIDI J 2005Vasc Health Risk Manag2005,1,3:1
171-year follow-up of autologous muscle-derived stem cell injection pilot study to treat stress urinary incontinence显示文摘Carr LK Steele D Steele S 2008Int Urogynecol J Pelvic Floor Dysfunct2008,19,6:1
18Sensitivity analysis for structural errors 显示文摘NOWAK A S CARR R I 1985Journal of the structural engineering1985,,8:1
19On the Fragility of Skilled Performance:WhatGoverns Choking Under Pressure 显示文摘BEILOCK S L CARR T H 2001Journal of Experimental Psychology:General2001,130,4:1
20Dipeptidyl peptidase- 1V inhibitor use associated with increased risk of ACE inhibitor-associated angioedema 显示文摘Brown N J Byiers S Carr D 2009Hypertension2009,54,3:1
返回顶部 每页显示:
共43页 首页 上一页 第1页 下一页 末页 /43 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费